downdraft
5 minutes ago
I think my revenue guess is way off. From the July 25, 2024 press release, in part...
"Knowing that most MS patients could not afford aHSCT, which typically cost on average $150,000 in the US, and that you have to qualify for the strict small trials being done in the US. I decided to